72SEVENTYBIO Trademark

Trademark Overview


On Saturday, August 21, 2021, a trademark application was filed for 72SEVENTYBIO with the United States Patent and Trademark Office. The USPTO has given the 72SEVENTYBIO trademark a serial number of 90895337. The federal status of this trademark filing is ABANDONED - EXPRESS as of Monday, January 24, 2022. This trademark is owned by 2seventy bio, Inc.. The 72SEVENTYBIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; genetically modified cells, genome editing reagents and viral vectors for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer

Pharmaceutical research and development
72seventybio

General Information


Serial Number90895337
Word Mark72SEVENTYBIO
Filing DateSaturday, August 21, 2021
Status601 - ABANDONED - EXPRESS
Status DateMonday, January 24, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized design of a 7 comprised of a dark elongated upper triangle and a light elongated lower triangle, with the stylized design of the 7 to left of "2SEVENTYBIO" in stylized lowercase letters. The elongated upper triangle has a rounded point at its upper right, and its lower side is curved inwardly where it interfaces with the lower elongated triangle, which has a rounded point at its upper right. "2SEVENTY" is bolded relative to "BIO".
Goods and ServicesPharmaceutical preparations and substances for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; genetically modified cells, genome editing reagents and viral vectors for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer
Goods and ServicesPharmaceutical research and development
Pseudo MarkSEVEN TO SEVENTY BIO; SEVEN TWO SEVENTY BIO; SEVENTY TWO SEVENTY BIO

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 8, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party Name2seventy bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, January 24, 2022ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Monday, January 24, 2022ABANDONMENT - EXPRESS MAILED
Friday, January 21, 2022TEAS EXPRESS ABANDONMENT RECEIVED
Monday, January 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 3, 2022NON-FINAL ACTION E-MAILED
Monday, January 3, 2022NON-FINAL ACTION WRITTEN
Tuesday, December 21, 2021ASSIGNED TO EXAMINER
Saturday, October 9, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, October 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, August 25, 2021NEW APPLICATION ENTERED IN TRAM